DTIL – precision biosciences, inc. (US:NASDAQ)

News

Precision BioSciences (DTIL) had its "buy" rating reaffirmed by JonesTrading. They now have a $30.00 price target on the stock.
Precision BioSciences, Inc. (DTIL) Presents at 25th Annual Needham Virtual Healthcare Conference Transcript [Seeking Alpha]
Precision BioSciences Expands ELIMINATE-B Trial Following Clinical Trial Application Approval in Two European Countries
Precision BioSciences to Participate in the 25th Annual Needham Virtual Healthcare Conference [Yahoo! Finance]
Precision BioSciences to Participate in the 25th Annual Needham Virtual Healthcare Conference
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com